{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-096025","form_type":"8-K","ticker":"INM","cik":"0001728328","company_name":"InMed Pharmaceuticals Inc.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.383277+00:00","generated_at":"2026-05-30T02:03:15.543924+00:00","sec_items":["3.03","7.01","8.01","9.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"InMed announces 1-for-20 reverse share split to regain Nasdaq $1 bid compliance","bullets":["Consolidation ratio 1:20 reduces shares from ~14.36M to ~718k on a non-diluted basis.","Effective with Nasdaq on Nov 14, 2024; adjusted trading begins Nov 15, symbol INM unchanged.","No fractional shares issued; fractions under 0.5 cancelled, otherwise rounded up.","Proportionate adjustment to exercise prices and share counts of options/warrants/convertibles.","Action taken to meet Nasdaq minimum $1.00 bid price continued listing requirement."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-096025","json":"https://secwatch.observer/filing/0001213900-24-096025.json","markdown":"https://secwatch.observer/filing/0001213900-24-096025.md","text":"https://secwatch.observer/filing/0001213900-24-096025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728328/000121390024096025/0001213900-24-096025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728328/000121390024096025/ea0220578-8k_inmed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:03:15.543924+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}